---
figid: PMC5253284__atm-05-01-4-f1
figlink: /pmc/articles/PMC5253284/figure/f1/
number: Figure 1
caption: Schematic illustration of the emergence of drug resistance to EGFR tyrosine
  kinase inhibitors highlighting the role of autocrine and paracrine MET/HGF pathway
  alterations and the preexistence of subclonal MET amplified drug-resistant cell
  subsets.
pmcid: PMC5253284
papertitle: MET/HGF pathway activation as a paradigm of resistance to targeted therapies.
reftext: Brian Ko, et al. Ann Transl Med. 2017 Jan;5(1):4.
pmc_ranked_result_index: '38255'
pathway_score: 0.738557
filename: atm-05-01-4-f1.jpg
figtitle: Schematic illustration of the emergence of drug resistance to EGFR tyrosine
  kinase inhibitors highlighting the role of autocrine and paracrine MET/HGF pathway
  alterations and the preexistence of subclonal MET amplified drug-resistant cell
  subsets
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5253284__atm-05-01-4-f1.html
  '@type': Dataset
  description: Schematic illustration of the emergence of drug resistance to EGFR
    tyrosine kinase inhibitors highlighting the role of autocrine and paracrine MET/HGF
    pathway alterations and the preexistence of subclonal MET amplified drug-resistant
    cell subsets.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - HGF
  - MET
  - EGFR
  - MEt
genes:
- word: HGF
  symbol: HGF
  source: hgnc_symbol
  hgnc_symbol: HGF
  entrez: '3082'
- word: MET
  symbol: MET
  source: hgnc_symbol
  hgnc_symbol: MET
  entrez: '4233'
- word: EGFR
  symbol: EGFR
  source: hgnc_symbol
  hgnc_symbol: EGFR
  entrez: '1956'
chemicals:
- word: MEt
  source: MESH
  identifier: D008715
diseases: []
---
